Surivival Benefit of Regorafenib in CORRECT and CONCUR Trials

Special Reports, Gastrointestinal Cancers (Issue 5), Volume 4, Issue 2

Axel Grothey, MD, medical oncologist, Mayo Clinic, discusses the survival benefit of regorafenib in CORRECT and CONCUR trials.